Epithelial-mesenchymal transition in the pathophysiology of airway remodelling in asthma

Current Opinion in Allergy and Clinical Immunology

Volumn 12, Issue 1, 2012, Pages 53-59

  Hackett, Tillie Louise ^a,b  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Adhesion junctions; Airway remodeling; Asthma; Epithelial mesenchymal transition

Indexed keywords

GROWTH FACTOR; MATRIX PROTEIN;

AIRWAY REMODELING; ASTHMA; CELL ADHESION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; HUMAN; INFLAMMATORY DISEASE; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; RESPIRATORY EPITHELIUM; REVIEW;

AIRWAY REMODELING; ASTHMA; CELL ADHESION; CHILD; EPITHELIAL-MESENCHYMAL TRANSITION; EPITHELIUM; HUMANS; TIGHT JUNCTIONS;

EID: 84856896936     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e32834ec6eb     Document Type: Review

References (68)

1. Gumbiner BM. Regulation of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol 2005; 6:622-634. (Pubitemid 41081266)
2. Halbleib JM, Nelson WJ. Cadherins in development: cell adhesion, sorting, and tissue morphogenesis. Genes Dev 2006; 20:3199-3214. (Pubitemid 44904842)
3. Nishimura T, Takeichi M. Remodeling of the adherens junctions during morphogenesis. Curr Top Dev Biol 2009; 89:33-54.
4. de Boer WI, Sharma HS, Baelemans SM, et al. Altered expression of epithelial junctional proteins in atopic asthma: possible role in inflammation. Can J Physiol Pharmacol 2008; 86:105-112. (Pubitemid 351536459)
5. Trautmann A, Kruger K, Akdis M, et al. Apoptosis and loss of adhesion of bronchial epithelial cells in asthma. Int Arch Allergy Immunol 2005; 138:142-150. (Pubitemid 41540671)
6. Hackett TL, Singhera GK, Shaheen F, et al. Intrinsic phenotypic differences of asthmatic epithelium and its inflammatory responses to RSV and air pollution. Am J Respir Cell Mol Biol 2011; 45:1090-1100. This parallel ex-vivo and in-vitro study of the asthmatic epithelium demonstrates an intrinsically altered phenotype and aberrant inflammatory response to common environmental challenges compared with nonasthmatic epithelium.
7. Xiao C, Puddicombe SM, Field S, et al. Defective epithelial barrier function in asthma. J Allergy Clin Immunol 2011; 128:549-556; e12. First study to demonstrate defective epithelial barrier function in asthma by loss of tight junction proteins and decreased transepithelial resistance in epithelial biopsies.
8. Holgate ST. Asthma: more than an inflammatory disease. Curr Opin Allergy Clin Immunol 2002; 2:27-29. (Pubitemid 34269867)
9. Holgate ST, Davies DE, Lackie PM, et al. Epithelial-mesenchymal interactions in the pathogenesis of asthma. J Allergy Clin Immunol 2000; 105 (2 Pt 1): 193-204. (Pubitemid 30109029)
10. Zeisberg M, Yang C, Martino M, et al. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 2007; 282:23337-23347. (Pubitemid 47311952)
11. Saika S, Kono-Saika S, Ohnishi Y, et al. Smad3 signaling is required for epithelial-mesenchymal transition of lens epithelium after injury. Am J Pathol 2004; 164:651-663. (Pubitemid 38364679)
12. Kim KK, Kugler MC, Wolters PJ, et al. Alveolar epithelial cell mesenchymal transition develops invivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci U S A 2006; 103:13180-13185. (Pubitemid 44338936)
13. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA dissemination committee report. Allergy 2004; 59:469-478. (Pubitemid 38580764)
14. WHO. Asthma. Fact sheet No. 307. http://wwwwhoint/mediacentre/factsheets/ fs307/en/indexhtml. [Accessed September 2011]
15. Horak E, Lanigan A, Roberts M, et al. Longitudinal study of childhood wheezy bronchitis and asthma: outcome at age 42. BMJ 2003; 326:422-423. (Pubitemid 36246312)
16. Jeffery PK. Remodeling and inflammation of bronchi in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 2004; 1:176-183.
17. Phelan PD, Robertson CF, Olinsky A. The Melbourne Asthma Study: 1964- 1999. J Allergy Clin Immunol 2002; 109:189-194. (Pubitemid 34158282)
18. Ward C,Pais M,BishR, et al. Airway inflammation, basementmembranethickening and bronchial hyperresponsiveness in asthma. Thorax 2002; 57:309-316. (Pubitemid 34298927)
19. Sears MR, Greene JM, Willan AR, et al. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 2003; 349:1414-1422. (Pubitemid 37211056)
20. Strachan DP, Griffiths JM, Johnston ID, Anderson HR. Ventilatory function in British adults after asthma or wheezing illness at ages 0-35. Am J Respir Crit Care Med 1996; 154 (6 Pt 1):1629-1635. (Pubitemid 26424926)
21. Bai TR, Knight DA. Structural changes in the airways in asthma: observations and consequences. Clin Sci (Lond) 2005; 108:463-477. (Pubitemid 40827554)
22. Demoly P, Simony-Lafontaine J, Chanez P, et al. Cell proliferation in the bronchial mucosa of asthmatics and chronic bronchitics. Am J Respir Crit Care Med 1994; 150:214-217. (Pubitemid 24209961)
23. Holgate ST. Novel targets of therapy in asthma. Curr Opin Pulm Med 2009; 15:63-71.
24. Swindle EJ, Collins JE, Davies DE. Breakdown in epithelial barrier function in patients with asthma: identification of novel therapeutic approaches. J Allergy Clin Immunol 2009; 124:23-34.
25. Nawijn MC, Hackett TL, Postma DS, et al. E-cadherin: gatekeeper of airway mucosa and allergic sensitization. Trends Immunol 2011; 32:248-255.
26. Foresi A, Bertorelli G, Pesci A, et al. Inflammatory markers in bronchoalveolar lavage and in bronchial biopsy in asthma during remission. Chest 1990; 98:528-535. (Pubitemid 20352676)
27. Jeffery PK, Wardlaw AJ, Nelson FC, et al. Bronchial biopsies in asthma: an ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 1989; 140:1745-1753. (Pubitemid 20041063)
28. Crosby LM, Waters CM. Epithelial repair mechanisms in the lung. Am J Physiol Lung Cell Mol Physiol 2010; 298:L715-L731.
29. Plopper CG, Smiley-Jewell SM, Miller LA, et al. Asthma/allergic airways disease: does postnatal exposure to environmental toxicants promote airway pathobiology? Toxicol Pathol 2007; 35:97-110. (Pubitemid 46328410)
30. Iwano M, Plieth D, Danoff TM, et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002; 110:341-350. (Pubitemid 34847966)
31. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003; 112:1776-1784. (Pubitemid 38063698)
32. Brewster CE, Howarth PH, Djukanovic R, et al. Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 1990; 3:507-511.
33. Benayoun L, Druilhe A, Dombret MC, et al. Airway structural alterations selectively associated with severe asthma. Am J Respir Crit Care Med 2003; 167:1360-1368. (Pubitemid 36609720)
34. Acloque H, Adams MS, Fishwick K, et al. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest 2009; 119:1438-1449.
35. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139:871-890.
36. Yang J, Weinberg RA. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 2008; 14:818-829. (Pubitemid 351757205)
37. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2:442-454.
38. Thiery JP, Sleeman JP. Complex networks orchestrate epithelial- mesenchymal transitions. Nat Rev Mol Cell Biol 2006; 7:131-142. (Pubitemid 43278296)
39. Zavadil J, Bottinger EP. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 2005; 24:5764-5774.
40. Thiery JP. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003; 15:740-746. (Pubitemid 37487967)
41. Boxall C, Holgate ST, Davies DE. The contribution of transforming growth factor-beta and epidermal growth factor signalling to airway remodelling in chronic asthma. Eur Respir J 2006; 27:208-229. (Pubitemid 43092684)
42. Holgate ST, Davies DE, Puddicombe S, et al. Mechanisms of airway epithelial damage: epithelial-mesenchymal interactions in the pathogenesis of asthma. Eur Respir J Suppl 2003; 44:24s-29s. (Pubitemid 37222058)
43. Hackett TL, Warner SM, Stefanowicz D, et al. Induction of epithelialmesenchymal transition in primary airway epithelial cells from patients with asthma by transforming growth factor-beta1. Am J Respir Crit Care Med 2009; 180:122-133.
44. Heijink IH, Postma DS, Noordhoek JA, et al. House dust mite-promoted epithelial-to-mesenchymal transition in human bronchial epithelium. Am J Respir Cell Mol Biol 2010; 42:69-79. This is the first study to look at the effects of environmental allergen, house dust mite, on induction of EMT in airway epithelial cells.
45. Borthwick LA, McIlroy EI, Gorowiec MR, et al. Inflammation and epithelial to mesenchymal transition in lung transplant recipients: role in dysregulated epithelial wound repair. Am J Transplant 2010; 10:498-509.
46. Borthwick LA, Parker SM, Brougham KA, et al. Epithelial to mesenchymal transition (EMT) and airway remodelling after human lung transplantation. Thorax 2009; 64:770-777.
47. Camara J, Jarai G. Epithelial-mesenchymal transition in primary human bronchial epithelial cells is Smad-dependent and enhanced by fibronectin and TNF-alpha. Fibrogenesis Tissue Repair 2010; 3:2. This is the first study to look at the effects of common asthma therapies on the mechanisms of EMT in airway epithelial cells.
48. Doerner AM, Zuraw BL. TGF-beta1 induced epithelial to mesenchymal transition (EMT) in human bronchial epithelial cells is enhanced by IL-1beta but not abrogated by corticosteroids. Respir Res 2009; 10:100.
49. Zhang M, Zhang Z, Pan HY, et al. TGF-beta1 induces human bronchial epithelial cell-to-mesenchymal transition in vitro. Lung 2009; 187:187-194.
50. Zhou BP, Deng J, Xia W, et al. Dual regulation of Snail by GSK-3betamediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 2004; 6:931-940. (Pubitemid 39359846)
51. Sporn MB. TGF-beta: 20 years and counting. Microbes Infect 1999; 1:1251-1253.
52. Zeisberg EM, Tarnavski O, Zeisberg M, et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 2007; 13:952-961. (Pubitemid 47222040)
53. Zeisberg M, Hanai J, Sugimoto H, et al. BMP-7 counteracts TGF-beta1- induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 2003; 9:964-968. (Pubitemid 36889942)
54. Murray LA, Hackett TL, Warner SM, et al. BMP-7 does not protect against bleomycin-induced lung or skin fibrosis. PLoS One 2008; 3:e4039.
55. Ekblom P. Genetics of kidney development. Curr Opin Nephrol Hypertens 1996; 5:282-287. (Pubitemid 26194562)
56. Molloy EL, Adams A, Moore JB, et al. BMP4 induces an epithelialmesenchymal transition-like response in adult airway epithelial cells. Growth Factors 2008; 26:12-22. (Pubitemid 351448010)
57. Borthwick LA, Gardner A, De Soyza A, et al. Transforming growth factor-beta1 (TGF-beta1) driven epithelial to mesenchymal transition (EMT) is accentuated by tumour necrosis factor alpha (TNFalpha) via crosstalk between the SMAD and NF-kappaB pathways. Cancer Microenviron 2011. DOI: 10.1007/s12307-011-0080-9.
58. Wan H, Winton HL, Soeller C, et al. The transmembrane protein occludin of epithelial tight junctions is a functional target for serine peptidases from faecal pellets of dermatophagoides pteronyssinus. Clin Exp Allergy 2001; 31:279-294. (Pubitemid 32231861)
59. Heijink IH, van Oosterhout A, Kapus A. Epidermal growth factor receptor signalling contributes to house dust mite-induced epithelial barrier dysfunction. Eur Respir J 2010; 36:1016-1026.
60. Zabner J, Winter M, Excoffon KJ, et al. Histamine alters E-cadherin cell adhesion to increase human airway epithelial permeability. J Appl Physiol 2003; 95:394-401. (Pubitemid 36753825)
61. Runswick S, Mitchell T, Davies P, et al. Pollen proteolytic enzymes degrade tight junctions. Respirology 2007; 12:834-842. (Pubitemid 350045730)
62. Johnson JR, Roos A, Berg T, et al. Chronic respiratory aeroallergen exposure in mice induces epithelial-mesenchymal transition in the large airways. PLoS One 2011; 6:e16175.
63. Grunert S, Jechlinger M, Beug H. Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat Rev Mol Cell Biol 2003; 4:657-665. (Pubitemid 36934968)
64. Janda E, Lehmann K, Killisch I, et al. Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J Cell Biol 2002; 156:299-313. (Pubitemid 34839911)
65. Hackett TL, Shaheen F, Johnson A, et al. Characterization of side population cells from human airway epithelium. Stem Cells 2008; 26:2576-2585.
66. Sidhu SS, Yuan S, Innes AL, et al. Roles of epithelial cell-derived periostin in TGF-beta activation, collagen production, and collagen gel elasticity in asthma. Proc Natl Acad Sci U S A 2010; 107:14170-14175. This study describes the elevation in periostin expression in airway epithelial cells of patients with asthma. This observation may have important consequences for activation of the EMTU in asthma.
67. Shahana S, Jaunmuktane Z, Asplund MS, Roomans GM. Ultrastructural investigation of epithelial damage in asthmatic and nonasthmatic nasal polyps. Respir Med 2006; 100:2018-2028. (Pubitemid 44490278)
68. Masszi A, Fan L, Rosivall L, et al. Integrity of cell-cell contacts is a critical regulator of TGF-beta 1-induced epithelial-to-myofibroblast transition: role for beta-catenin. Am J Pathol 2004; 165:1955-1967. (Pubitemid 39578374)